Welcome to our dedicated page for Genesco SEC filings (Ticker: GCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sneaker trends shift quickly, but Genesco Inc’s multi-brand footprint—Journeys, Schuh, Johnston & Murphy, and Licensed Brands—means its SEC filings map revenue across youth fashion, premium dress shoes, and licensed labels. That breadth creates filing complexity, from segment margin footnotes to wholesale versus retail disclosures. If you’re looking for “Genesco SEC filings explained simply,” this page is your starting line. Stock Titan’s AI reads the fine print so you can focus on what moves the stock.
Need the next “Genesco quarterly earnings report 10-Q filing”? It lands here seconds after EDGAR posts, already parsed for same-store sales swings and inventory turnover. The annual report—searchable as “Genesco annual report 10-K simplified”—distills store count trends, lease obligations, and digital channel growth. Material announcements are flagged under “Genesco 8-K material events explained,” while “Genesco proxy statement executive compensation” breaks down incentive plans without the legalese.
Many visitors track “Genesco insider trading Form 4 transactions” to see when executives buy or sell shares. Our dashboard highlights “Genesco Form 4 insider transactions real-time,” connects them to business milestones, and offers “Genesco earnings report filing analysis” side-by-side. From “understanding Genesco SEC documents with AI” to identifying “Genesco executive stock transactions Form 4,” Stock Titan turns regulatory text into actionable knowledge, helping you compare quarters, monitor cash flow, and act with confidence.
Nomura Holdings, Inc. and its subsidiary Nomura Global Financial Products, Inc. report beneficial ownership of Genesco Inc. common stock totaling 422,732 shares (Nomura Holdings) and 422,678 shares (NGFP) with shared voting and dispositive power. The reported holdings represent 3.9% of Genesco's outstanding shares, calculated on a base of 10,778,805 shares as disclosed in the issuer's quarterly report as of May 30, 2025. The filing indicates the shares are held in the ordinary course of business and were not acquired to influence control of the issuer. Exhibits include a joint filing agreement and a list of subsidiaries.